Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
AGIO: Agios Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
AGIO
The Story
AGIO
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+36.1% / yr
Operating margin
-720.0%
ROIC
-43.1%
Financially safe
Stretched
Debt / equity
0.03×
Interest coverage
0.0×
Current ratio
8.52×
Agios Pharmaceuticals, Inc.
AGIO
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Agios Pharmaceuticals, Inc.
AGIO
NASDAQ
·
USD
·
Closed
$30.02
−8.34%
$30.02
−$2.73 (8.34%)
52W Range
33th
pctl
Volume
1.91×
avg
Mkt Cap
1.79B
USD
P/E
-5.1
TTM
Div Yield
–
ann
52W Range
33th
pctl
Volume
1.91×
avg
Market Cap
1.79B
USD
P/E Ratio
-5.1
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings